CIK: 0001703031
Total reported value
$1.1B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SWTXUSD | Springworks Therapeutics INC | Stock-Other | 41.80% | — | — | |
| 2 | CNST | Constellation Pharmaceutical | Stock-Other | 19.84% | — | — | |
| 3 | DRNAUSD | Dicerna Pharmaceuticals INC | Stock-Other | 13.41% | — | -44.34% | |
| 4 | DVAX | Dynavax Technologies CORP | Stock-Other | 7.21% | — | — | |
| 5 | REPL | Replimune Group INC | Stock-Other | 6.08% | — | — | |
| 6 | SVRA | Savara INC | Stock-Other | 3.43% | +0.54% | — | |
| 7 | ASNSUSD | X4 Pharmaceuticals INC | Stock-Other | 2.63% | — | — | |
| 8 | SLDB | Solid Biosciences Inc. | Stock-Other | 2.57% | — | — | |
| 9 | MRNSUSD | Marinus Pharmaceuticals INC | Stock-Other | 1.91% | — | +17.85% | |
| 10 | ✓ | Aptinyx INC | Stock-Other | 1.13% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | SWTXUSD | Springworks Therapeutics INC | +1.2% | — | Unchanged |
| 2 | MRNSUSD | Marinus Pharmaceuticals INC | -0.1% | +17.85% | Add |
| 3 | DVAX | Dynavax Technologies CORP | -0.6% | — | Unchanged |
| 4 | ✓ | Aptinyx INC | -0.9% | — | Unchanged |
| 5 | REPL | Replimune Group INC | -4.1% | — | Unchanged |
| 6 | SLDB | Solid Biosciences Inc. | -7.7% | — | Unchanged |
| 7 | DRNAUSD | Dicerna Pharmaceuticals INC | -13.7% | -44.34% | Trim |
| 8 | CNST | Constellation Pharmaceutical | — | NEW | New buy |
| 9 | SVRA | Savara INC | — | NEW | New buy |
| 10 | ASNSUSD | X4 Pharmaceuticals INC | — | NEW | New buy |